The SwedishDrug Discovery and DevelopmentPipeline 2023

March 23, 2023

Sweden is and should remain a leading life sciences
nation. The life sciences industry is one of Sweden’s
economic base industries with a signifi cant share
of our exports.

Spotlight

Enable Injections, Inc.

Enable Injections is pioneering a new class of drug delivery technology, the wearable high-volume injector, that industry experts are calling “truly revolutionary.” Winner of Buzz of BIO Investor Forum and other accolades, the Enable Injections technology is designed to allow easy, comfortable self-administration of the more than 900 high volume, viscous biologics in development--promising new drugs to treat a host of conditions from cancers and autoimmune diseases to genetic and rare diseases that, because of the large doses required, cannot be delivered with today’s legacy injection technology. Founded in 2010 by medical device industry veterans, the company has R&D and manufacturing facilities in Franklin, Ohio.

OTHER WHITEPAPERS

Combatting Future Viral Threats with Vaccine Advances

whitePaper | February 3, 2023

Since the beginning of the COVID-19 pandemic, pharmaceutical organizations have experienced major changes, a prime example of which has been the rising requirement for collaborations on multiple different fronts across the industry.

Association for Accessible Medicines Drug Shortages

whitePaper | June 22, 2023

Generic medicines are the backbone of the U.S. prescription drug market, supplying more than 9 out of every 10 prescriptions. And the availability of generic medicines overall is remarkably stable even during challenges such as the COVID-19 pandemic.

Advancing drug development using in silico modeling

whitePaper | June 22, 2022

The technologic and pharmacologic advances that have enabled researchers to take aim at previously untreatable diseases have contributed to an increase in the number of molecules in the development pipeline that are challenging and difficult to manufacture.

Employing Singleuse Technology to Control Frozen Bulk Drug Storage

whitePaper | September 29, 2022

New biopharmaceutical drug products that alter and even save lives can be very profitable for their developers.

Prescription Drug Pricing: How Lack of Transparency Reduces Market Access, Utilization, and Adherence

whitePaper | November 25, 2019

It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers.